Runhui Wu

Director and Physician in Chief
Beijing Children’s Hospital, Capital Medical University, Beijing, China

Presentation(s):

• OC 27.3 - Individualized target trough FVIII level and optimized prophylaxis in pediatric patients with hemophilia A

  Sunday, July 10, 2022
  3:15 PM – 3:30 PM

• VPB0149 - Single nucleotide polymorphisms of the HIF1A gene are associated with sensitivity of glucocorticoid treatment in pediatric ITP patients

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• VPB0289 - -T cells predict the response of High-dose dexamethasone in pediatric newly dignosed immune thrombocytopenia

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• VPB0313 - Treatment and prognosis of children with inherited TTP: a single-center retrospective clinical study

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• OC 40.3 - Consumption of On-demand Factor Concentrates and Bypassing Agents for Management of Breakthrough Bleeds with Fitusiran Prophylaxis in People with Haemophilia A or B: An Analysis of Two Phase 3 Studies

  Monday, July 11, 2022
  3:15 PM – 3:30 PM

• PB0664 - Demographic and Baseline Clinical Characteristics of Patients With Hemophilia A in China: Real-world Data From the AHEAD International Study

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• VPB0692 - Enhanced pharmacokinetics and improved clinical outcomes in young hemophiliac boys after the switch to BAY 81-8973 from other standard half-life FVIII concentrates

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• VPB0697 - Efficacy, Safety and Pharmacokinetics of Recombinant Human Coagulation Factor VIII (SCT800) in Previously Treated Children with Severe Hemophilia A.

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• VPB1166 - Eradication of FIX inhibitor in haemophilia B children: A retrospective study from haemophilia pediatric comprehensive care center of China

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM